(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

CONJUGADO DE ANTICORPO-FÁRMACO

ArquivadaInvention PatentPCT · IB2023057251

Application data

Number

112025000657

Type

Invention Patent

Filing

07/15/2023

Publication

06/10/2025

PCT

IB2023057251

Progress at the INPI

  1. Filing07/15/23
  2. Publication06/10/25
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 07/15/2023 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 07/21/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PHEON THERAPEUTICS LTD

GB

Inventors

D. T. (pessoa física)

GB

G. P. (pessoa física)

GB

L. Z. (pessoa física)

GB

P. J. (pessoa física)

GB

Technical data

Priority claims

US

63/389,743 · 07/15/2022

US

63/400,703 · 08/24/2022

US

63/489,473 · 03/10/2023

US

63/489,474 · 03/10/2023

Abstract

CONJUGADO DE ANTICORPO-FÁRMACO. A presente invenção refere-se a conjugados de anticorpofármaco (ADCs), ligantes e compostos destes úteis para tratar câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 33 da LPI

#11.1

07/21/2026

RPI 2898

Notificação de entrada na fase nacional - PCT

#1.3

06/10/2025

RPI 2840

Alteração de dados cadastrais

#1.1

02/04/2025

RPI 2822

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.